Clinical Trial Update: Study of the Effectiveness of Telmisartan in Slowing the Progression of Abdominal Aortic Aneurysms [Phase 4]

View source ↗

Summary

Phase 4 trial assessing telmisartan's effectiveness in slowing progression of abdominal aortic aneurysm has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Abdominal Aortic Aneurysm

Drugs mentioned

• Telmisartan (Telmisartan)

Snippet

Sponsor: Palo Alto Veterans Institute for Research | Conditions: Abdominal Aortic Aneurysm | Phase 4 | Status: COMPLETED